← Back to Clinical Trials
Recruiting NCT04577313

HIV Treatment Adherence Dose Determination Trial

◆ AI Clinical Summary

This study tests how many counseling sessions help people with HIV take their medications as prescribed. Researchers want to find the right amount of support needed to help patients stay healthy and manage their treatment effectively.

Key Objective: The trial tests whether behavioral counseling helps HIV patients take their medications consistently and improves their health outcomes.

Who to Consider: People with HIV who want to improve their medication adherence and are interested in receiving counseling support should consider enrolling.

Trial Parameters

Condition HIV Infections
Sponsor University of Connecticut
Study Type INTERVENTIONAL
Phase N/A
Enrollment 400
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2020-09-01
Completion 2026-11-30
Interventions
Behavioral Self-Regulation Adherence Counseling

Brief Summary

The proposed research will conduct the first dose-determination trial to find the optimal number of behavioral counseling sessions (dose) needed to achieve and sustain optimal HIV treatment adherence. The results of this study will determine how much intervention is needed for whom and at what cost to guide health policy and implementation of behavioral interventions designed to improve durable viral suppression.

Eligibility Criteria

Inclusion Criteria: * Confirmed HIV positive * Confirmed prescribed antiretroviral therapy * Confirmed non-adherent to anti-retroviral therapy Exclusion Criteria: * Does not have access to a phone * Does not have access to the internet

Related Trials